FSD Pharma Unveils Videos Demonstrating Effects Of Lucid-MS In Treating Multiple Sclerosis In Pre-Clinical Models
Author: Bill Haddad | December 02, 2021 09:06am
FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE) (FRA: 0K9) ("FSD Pharma" or the "Company"), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, announced today that it is sharing pre-clinical data, supported by an explanatory video, demonstrating the potentially disease-modifying effects of Lucid-MS, the Company's lead drug candidate for the potential treatment of multiple sclerosis ("MS"), in the animal models of MS.
Posted In: CSE:HUGE HUGE